US, Europe, and South Africa Microbial Recombinant Proteins Market Size By Production Platform (Mammalian Cell, Microbial (E Coli) Cell), By End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies), By Repairs & Maintenance (Electricity, Plumbing), By Geographic Scope And Forecast

US, Europe, and South Africa Microbial Recombinant Proteins Market Size And Forecast

US, Europe, and South Africa Microbial Recombinant Proteins Market size was valued at USD 700.82 Million in 2021 and is projected to reach USD 1,600.88 Million by 2030, growing at a CAGR of 9.95% from 2022 to 2030.

Excellent use in biotherapeutics and biomedical research to understand health and disease is expected to boost market growth. Additionally, the increasing use of microbial recombinant proteins in medicine and research is expected to grow the market. The Global US, Europe, and South Africa Microbial Recombinant Proteins Market report provide a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

US, Europe, and South Africa Microbial Recombinant Proteins Market Definition

All living things manufacture proteins as a critical component of their natural metabolism since proteins are life’s primary structural building blocks. Proteins exist in many forms and play essential roles in keeping the body functioning from birth to death. Examples include Enzymes, Biocatalysts for metabolic reactions, Antibodies that are used in immunological responses, and Most structural proteins. The protein can be produced in two different methods, either in recombinant form, to create beneficial products for the biopharmaceutical, enzyme, and agricultural industries. Due to its cheap availability in huge quantities, genetic engineering-based recombinant proteins (r-proteins) application is currently considerably more concentrated.

US, Europe, and South Africa Microbial Recombinant Proteins Market Overview

Excellent use in biotherapeutics and biomedical research to understand health and disease is expected to boost market growth. Recombinant proteins are valuable tools in understanding protein interactions. Protein interactions are seen as stable or transient and play an essential role in cellular processes. Recently, RP microarrays testing for protein-protein interactions have become popular. This way, researchers detect a slide of high-density protein and then treat it with different molecules to test how the two agents interact. Using this process, scientists have studied the interaction of proteins with other proteins or peptides, enzymes, small molecules, lipids, and nucleic acids. This allows for much higher output when studying protein interactions. Additionally, the increasing use of microbial recombinant proteins in medicine and research is expected to grow the market. Many human diseases are related to a systemic or partial reaction to specific proteins. Therapeutic proteins provide essential therapies for various ailments, such as diabetes, cancer, infectious diseases, hemophilia, and anemia. Common therapeutic proteins include hormones, interleukins, antibodies, FC fusion proteins, enzymes, and anticoagulants. There is a growing need for recombined protein for medical purposes. Human proteins derived from genetic engineering play an important role in the pharmaceutical market. Currently, most of the combined therapeutic proteins are produced in mammalian cells because mammal cells can produce high-quality proteins similar to those naturally occurring. In addition, many of the combined therapeutic proteins are produced in E.coli due to their well-defined genes, rapid growth, and high yield production.

However, time-consuming extraction and expensive process is expected to hinder the market growth. Toxic, unstable, or easily digested proteins may benefit from production as synthetic bodies. But since there is no guarantee that the embedded bodies will regenerate or result in a high yield of coagulated protein (Baneyx 1999), it is not appropriate to produce proteins as ingested bodies. For all proteins, certain conditions during folding should be developed with respect to the composition of the bath, the temperature, and the concentration of the protein (Lilie et al. 1998). In addition, it is more expensive and time-consuming to clean and replenish implants than to purify soluble proteins (Sorensen and Mortensen 2005). Therefore, the production of embedded bodies is not an exciting program for high productivity due to the increase in the duration of these processes.

Furthermore, increasing new microbial cultivation methods and techniques for improved characteristics of recombinant proteins is expected to offer lucrative growth opportunities for market growth.

US, Europe, and South Africa Microbial Recombinant Proteins MarketSegmentation Analysis

The “US, Europe, and South Africa Microbial Recombinant Proteins Market” is divided into three segments, i.e., Production Platform, End User, Repairs & Maintenance, and Region.

US, Europe, and South Africa Microbial Recombinant Proteins Market, By Production Platform

• Mammalian Cell• Microbial (E Coli) Cell• Plant Cell• Insect Cell• Others

To Get Summarized Market Report By Production Platform-

On the basis of the Production Platform, the U.S., Europe, and South Africa Microbial Recombinant Proteins Market have been segmented into Mammalian Cell, Microbial (E Coli) Cell, Plant Cell, Insect Cell, and Others. Mammalian Cell accounted for the largest market share in 2021 and is projected to grow at a CAGR of 9.88% during the forecast period. Microbial (E Coli) Cell was the second-largest market in 2021. Mammalian cell culture is the process of cultivating cells in a growth media as opposed to their original tissue. The medium includes minerals, vitamins, amino acids, salts, oxygen and CO2, and growth factors to preserve cell integrity. Bovine serum is present in several mediums, although this has the drawbacks of poor repeatability and possible contaminations. Mammalian cell culture is now a crucial technology in many biotechnological and medicinal applications. The production of biological products including antibodies, synthetic hormones, and enzymes uses mammalian cell culture.

US, Europe and South Africa Microbial Recombinant Proteins Market, By End User

• Pharmaceutical & Biopharmaceutical Companies• Biotechnology Companies• Academic Research Institutes• Contract Research Organizations• Others

On the basis of End User, the US, Europe and South Africa Microbial Recombinant Proteins Market has been segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Pharmaceutical & Biopharmaceutical Companies accounted for the largest market share in 2021 and is projected to grow at the highest CAGR of 11.06% during the forecast period. Biotechnology Companies was the second-largest market in 2021. Several significant pharmaceutical companies have invested in recombinant DNA technologies and proteins to combat the pandemic. In April 2020, Sanofi and GSK teamed up to create vaccines using GSK’s adjuvant technology and Sanofi’s recombinant S-protein COVID-19 antigen. Additionally, several acquisitions are taking place to support R&D to produce recombinant proteins. Recombinant antibodies for COVID-19 infection are being developed by pharmaceutical and biopharmaceutical companies. For instance, Sanofi and GSK announced the beginning of a new Phase 2b research in February 2021 with 720 volunteers who were 18 years of age or older to determine the best antigen dosage for the Phase 3 assessment of their adjuvanted recombinant protein COVID-19 vaccine candidate.

US, Europe and South Africa Microbial Recombinant Proteins Market, By Repairs & Maintenance

• Electricity• Plumbing• Non-HVAC Home Appliances• Gas• Heating• Ventilation and Air Conditioning• Others

On the basis of Repairs & Maintenance, the US, Europe and South Africa Microbial Recombinant Proteins Market has been segmented into Electricity, Plumbing, Non-HVAC Home Appliances, Gas, Heating, Ventilation and Air Conditioning, and Others. Electricity accounted for the largest market share in 2021 and is projected to grow at a CAGR of 21.34% during the forecast period. Plumbing was the second-largest market in 2021. Home services offer a simple and easy way to deal with home repair of electrical lines in order to provide fast and reliable emergency repair services. Using an online or offline mode of home service, one can easily fix an appointment with an electrician. Online home services also give customers an option of choosing an electrician of their own choice. In a digital world, electricity holds great importance. Any blown circuit or as serious as damage to the exterior line or hardware needs to be repaired or replaced by an electrician.

US, Europe and South Africa Microbial Recombinant Proteins Market, By Geography

• United States• Europe• South Africa

To Get Summarized Market Report By Geography- 

The US, Europe and South Africa Microbial Recombinant Proteins Market are segmented on the basis of Region into the United States, Europe, and South Africa. As seen in the above figure, the US accounted for the largest market share in 2021 and is projected to grow at a CAGR of 9.84% during the forecast period. Europe was the second-largest market in 2021.

Key Players

The major players in the market are BioTech Africa, BBI Solutions, ACROBiosystems, Kaneka Eurogentec S.A., Biocon, Cape Bio Pharms, Thermo Fisher Scientific, Inc., Merck KGaA, Cape Biologix Technologies, Miltenyi Biotech, Biolegend, Enzo Life Sciences, Inc., Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., STEMCELL Technologies Inc., ProSpec-Tany TechnoGene Ltd, and Others.

Key Developments

• Thermo Fisher Scientific Inc., the market leader in offering services to the scientific establishment, and PeproTech, Inc., a leading developer and producer of recombinant proteins, announced that Thermo Fisher successfully completed the acquisition of PeproTech on December 30, 2021, for a total cash purchase price of approximately $1.85 billion.

Report Scope

To Get Customized Report Scope- 

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any <a href="https//www.marketresearch.